IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Paradigm Biocapital Advisors LP

Q4 2025 Holdings

Filed 2026-02-17 | 30 holdings | $3.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Nuvalent Inc(NUVL)COM670703107$530.1M5,269,43313.5%
Revolution Medicines Inc(RVMD)COM76155X100$529.2M6,644,40313.5%
Arcellx Inc(ACLX)COMMON STOCK03940C100$373.2M5,724,0169.5%
Genmab A/S(GMAB)SPONSORED ADS372303206$216.8M7,039,8345.5%
Tarsus Pharmaceuticals Inc(TARS)COM87650L103$209.8M2,562,1545.4%
Abivax SA(ABVX)SPONSORED ADS00370M103$191.2M1,417,4734.9%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$188.6M7,544,1724.8%
Vaxcyte Inc(PCVX)COM92243G108$187.7M4,068,0204.8%
Spdr Series Trust(XBI)PutSTATE STREET SPD78464A870$182.9M1,500,0004.7%
Cidara Therapeutics Inc(CDTX)COM NEW171757206$167.8M759,5654.3%
Edgewise Therapeutics Inc(EWTX)COM28036F105$162.3M6,541,2104.1%
Scholar Rock Hldg Corp(SRRK)COM80706P103$134.9M3,062,1573.4%
Urogen Pharma LTD(URGN)COMM96088105$104.8M4,473,6482.7%
Crinetics Pharmaceuticals in(CRNX)COM22663K107$102.9M2,210,7742.6%
Apogee Therapeutics Inc(APGE)COM03770N101$84.8M1,123,2432.2%
Eyepoint Inc(EYPT)COM NEW30233G209$67.4M3,691,4751.7%
Erasca Inc(ERAS)COM29479A108$52.7M14,159,0951.3%
Bridgebio Pharma Inc(BBIO)COM10806X102$52.3M684,2771.3%
Oruka Therapeutics Inc(ORKA)COM687604108$51.8M1,710,3161.3%
Spyre Therapeutics Inc(SYRE)COM NEW00773J202$48.1M1,467,2661.2%
Lexeo Therapeutics Inc(LXEO)COM52886X107$47.3M4,763,1981.2%
Viridian Therapeutics Inc(VRDN)COM92790C104$44.9M1,443,1021.1%
Ocular Therapeutix Inc(OCUL)COM67576A100$35.6M2,935,2840.9%
Terns Pharmaceuticals Inc(TERN)COM880881107$32.7M810,2860.8%
Bridgebio Oncology Therapeut(BBOT)COM NEW107924102$28.3M2,261,7490.7%
VOR Biopharma Inc(VOR)COM NEW929033207$22.9M1,750,0000.6%
Assembly Biosciences Inc(ASMB)COM NEW045396207$22.6M665,2510.6%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$19.6M2,401,2170.5%
Inventiva SA(IVA)ADS46124U107$18.6M4,000,0000.5%
Kalaris Therapeutics Inc(KLRS)COM482929106$5.9M700,0000.2%